Monday, 11 November 2019

Post-Traumatic Stress Disorder (PTSD) Market 2019 is Expected to Surge with 4.8% CAGR by 2025

Market Highlights
According to MRFR analysis, the global post-traumatic stress disorder (PTSD) market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 and was valued at USD 7.3 billion in 2018.
Post-Traumatic Stress Disorder (PTSD) develops when a person is exposed to a traumatic event such as warfare, violent sexual assault, or other severe threats on a person’s life. A person with PTSD is at a higher risk for suicide and intentional self-harm. Children under the age of 10 are less likely to develop PTSD than adults. Prevention is possible when therapy is targeted at those with early symptoms but is not valid when carried out among all people following trauma. The chief treatments for people with PTSD are counseling and medication.
The global post-traumatic stress disorder (PTSD) market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.
Key Players
Some of the key players in the global post-traumatic stress disorder (PTSD)  market are Azevan Pharmaceuticals (US), Marinus Pharmaceuticals, Inc. (US), Bionomics (Australia), Greenstone LLC (US), GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), H. Lundbeck A/S (Denmark), Tonix Pharmaceuticals Holding Corp. (US), and Mylan NV (US).
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of PTSD and rising per capita healthcare expenditure. The post-traumatic stress disorder (PTSD) market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European post-traumatic stress disorder (PTSD) market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The post-traumatic stress disorder (PTSD) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Asia Pacific region is the fastest region due to the increasing cases of sexual assault and road accidents and raising awareness about the treatment methods. The post-traumatic stress disorder (PTSD)  market in the Middle East & Africa has been divided into the Middle East and Africa.
Segmentation
The global post-traumatic stress disorder (PTSD) market has been segmented based on treatment and end user.
The market, based on treatment, has been divided into psychotherapy and medication. The psychotherapy has been further segmented into cognitive therapy, exposure therapy, and eye movement desensitization and reprocessing (EMDR). The medication has been segmented into antidepressants, anti-anxiety medications, and prazosin. The antidepressants are classified as paroxetine, sertraline,      mirtazapine, and amitriptyline, or phenelzine. The anti-anxiety drugs have been classified as beta-blockers and benzodiazepines. The medication segment is expected to hold the largest segment during the forecasted period.
The end user segment of the market are hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and surgery.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Mobile tablets in healthcare Market Anticipated to Grow at a Significant Pace by 2025

Market Highlights
According to MRFR analysis, the global mobile tablets in healthcare market is expected to register a CAGR of ~3.8% during the forecast period of 2019 to 2025 and ~ 30 units was sold in 2018.
Tablets are gaining collective foothold in the healthcare sector across all segments. Tablets are improving patient care wellness programs, laboratories, hospitals, clinic management systems, pharmaceutical services, and biotechnological advancements.
With doctors progressively using their tablets to manage and maintain their schedules and reminders, the healthcare industry is now forced on building applications that are enhanced for tablet use. These applications provide the combination of existing information systems and introduce tablets as a form for both data gathering and dissemination of critical information.
New and emerging advancements in technology in the healthcare industry have enabled patient monitoring devices and instrumentation to communicate directly with tablets using tools such as Bluetooth. These devices can also upload patient data using a Wi-Fi network over the web, which can then be monitored in real-time by physicians and doctors.
Segmentation
The global mobile tablets in healthcare market has been segmented based on application and end user.
The market, based on application, has been divided into patient monitoring and data collection, prescribing & issuing medicine, dashboard and reports, and appointment scheduling. The patient monitoring and data collection segment is expected to be the largest market owing to the growing use of mobile tablets by healthcare professionals and doctors. Further, mobile tablets help in managing patient data, and it proves to be a very useful device for healthcare professionals to adopt in their day to day activities.
Further, the end user segment is divided into hospitals, government organizations & research centers, ambulatory surgical centers, pharmacies, and laboratories.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the established healthcare industry and rising per capita healthcare expenditure. The mobile tablets in healthcare market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European mobile tablets in healthcare market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The mobile tablets in healthcare market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rising opportunity for tablet manufacturers to find a huge customer pool of mobile tablets in healthcare and rising healthcare infrastructure, the market in Asia-Pacific is expected to be the fastest-growing. The mobile tablets in healthcare market in the Middle East & Africa has been divided into the Middle East and Africa.
Key Players
Some of the key players in the global mobile tablets in healthcare market are Hewlett-Packard (US), Barco (Belgium), Apple Inc (US), Microsoft Corporation (US), Samsung Group (South Korea), Sand Dune Ventures, Inc (US), Zebra Technologies Corp (US), Teguar Computers (US), Advantech Co., Ltd (Taiwan), ARBOR Technology Corp (Taiwan), Dell (US), ASUSTeK Computer Inc (Taiwan), and HCL Technologies (India).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Friday, 8 November 2019

Medical Implants Market Has Taken a Significant Growth in Coming Years 2019-2023

Global Medical Implants Market likely to Exhibit a rapid growth over the next couple of years. United States, Europe and Asia emerging as the key growth-engines for the market in this region.
Medical Implants Market Key Players
Some prominent market players that have been profiled in MRFR's competitive analysis include Medtronic, Smith & Nephew, Dentsply Sirona, Boston Scientific Corporation, Johnson & Johnson Services Inc., 3M Company, Stryker Corporation, Zimmer Biomet Holdings Inc., and Institut Straumann AG.

Medical Implants Market Insights
Medical implants are always in the news a society where Hollywood stars and supermodels are deities. Sometimes, the news is about a Hollywood star getting some kind of implants and denying it in an “exclusive interview.” Sometimes, the news is about a celebrity promising to refuse implants or any kind of surgery to look young and “grow old naturally.” The culture propagated by media makes people curious about getting implants. Some do it out of medical necessities. But some do it out of curiosity or to look like their favorite star. However, the technique that made medical implants possible aimed to replace missing or damaged biological structure of the body. Some people may see implants as a way of interfering with nature, but necessity is the mother of invention and technique of medical implants was invented as a remedy to various chronic ailments.
A research report about the global medical implants market, published by Market Research Future (MRFR) has predicted 7.07% CAGR during the forecast period between 2017 and 2023. The key reasons that are boosting the global medical implants market are acceptance of advanced medical implants devices by patients, improvement of surgical outcomes, increasing aging population around the world, and rising prevalence of chronic disease. Rising consumer awareness about various preventive cares and repairs associated with the body and rapidly increasing population worldwide are contributing to the growth of the medical implants market globally. Increasing spending in healthcare domain also fuels the growth of medical implants market. 


Medical Implants Market Regional Analysis
The regional segmentation of the global medical implants market consists of the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas dominate the global medical implants market due to the increasing prevalence of chronic diseases. However, due to technological advancement, high health care spending, increasing geriatric population and various research & development (R&D) activities being funded by governments, are expected to be the key factors strengthening the market during the forecast period. The high cost of the devices and ambiguous regulatory framework are likely to have a negative impact on the market. Most of the key players in the global medical implants market in North America are based in the United States of America (USA). Among the Americas, North America might be a bigger market, but South America is growing rapidly and catching up with the former. Europe market which is the second largest regional market comprises of Eastern Europe and Western Europe. Due to advanced medical facilities, better living standards, more prosperity, Western Europe generates more revenue for medical implants market and the biggest markets in Western Europe are countries namely France, Italy, Spain and the United Kingdom (UK). The factors boosting the Europe market for medical implants are increasing support from the government, the presence of huge geriatric population, and high health care spending. Many European countries encourage the manufacturers for research & development (R&D) for the introduction of advanced devices. In addition to this, increasing awareness and developed healthcare infrastructure has provided a push to the growth of the market. However, strict regulatory rules can hinder the progress. Among all regional markets, Asia Pacific is the fastest growing market owing to more number of developing nations present in this region. The countries in this region are encouraging the growth of the medical implants devices, and the biggest markets here are Australia, China, India, Japan and South Korea. Remaining countries of Asia Pacific region also have a huge demand for medical implants, and they provide substantial revenue for the market. Contrary to the Asia Pacific region, the MEA region is a smaller market. However, it is likely to grow rapidly during the forecast period. This region has a smaller market not because of lack of demand but because of poor and slow developing countries, especially, in the African region.


Medical Implants Market Segmentation
The global medical implants market has been segmented by type, type of material, end-user, and region.
By type, the market has been segmented into orthopedic implant, cardiac implant, spinal implant, dental implant, ophthalmic implant, cosmetic implants and others. Presently, the orthopedic implant segment possesses nearly one-third of the total market share. However,  the cardiac implant segment is expected to grow at an impressive CAGR of 7.63 during the forecast period of 2017 to 2023.
By type of material, the market has been segmented into metallic material, ceramic material, polymers material and others.
By end user, the market has been segmented into hospitals & clinics, research laboratories, and others.
 By region, the global market has been segmented into the Americas, Europe, the Asia-Pacific, and the Middle East & Africa.

Hottest Trending Reports



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

CBD (Cannabidiol) Hemp Oil Market Global Demand and Forecast (2019 to 2023)

MarketResearchFuture.com (MRFR) in it’s Recently Announced study report asserts that the “Global CBD Hemp Oil Market” the report offer detailed insights about the Historical Trends and Current Scenario with Top Industry Players, Demand, Major Drivers and Industry Dynamics up to 2023.
CBD Hemp Oil Market – Overview
As CBD is the next most prevalent cannabinoid, its application and demand have grown at a rapid pace in recent years. Market reports connected with the healthcare industry have been offered by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is projected to develop at a positive rate in the upcoming forecast period.
The applications of CBD in pain relief, for the treatment of cancer symptoms, and its effect in reducing anxiety and depression is a major driver for the CBD hemp oil market. Thus, the application of CBD in relief and assist treatment is also being meaningfully expanded to other application areas to improve the market’s progress in the forecast period. Moreover, the application of CBD in the treatment topical skin problems is anticipated to boost the prospects available for the growth of the market.
Segmental Analysis
The segmentation of the CBD hemp oil market is carried out on the basis of application, region, product type, and distribution channel. On the basis of product type, the market for CBD hemp oil has been segmented into vape oil, spray, tincture, and others. On the basis of application, the market is segmented into pain relief, neurological disorder, diabetes, mood disorders, fibromyalgia, and others. Based on distribution channel, the CBD hemp oil market has been segmented into medical marijuana dispensaries, hospital pharmacies, retail pharmacies, e-commerce websites, and others. The regions considered in the market are Latin America, the Middle East, Europe, Africa, North America, and the Asia Pacific
Global CBD Hemp Oil Market - Geographical Analysis
The North American region backed by its largest production and consumption of the product for medicinal purposes, accounts for a leading market for CBD Hemp Oil. Additionally, factors such as the legal acceptance of CBD oil in various North American countries and the increasing application of CBD hemp oil in pharmaceutical products fosters the growth in the regional market.
Besides, North America is a hub for those CBD-based medicine companies. In North America, annually an increasing number of advancements of medical science, biotechnology, medicines/ pharma, and technology take place.
Due to the increasing consumption of CBD hemp oil in countries such as Turkey, Australia, and the Philippines the Asia Pacific region is expected to emerge as a promising market, globally. Moreover, Continuous research on the CBD hemp oil to bring out value-added products have been contributing to the growth of the CBD hemp oil market in the APAC.
Competitive Analysis
The employment of product differentiation has led to a favorable product differentiation scenario that is complementing the market’s growth. The participants in the market are trying to establish several USPs that will enable them to capture a more substantial share of the market. Additionally, the vertical additions and product tactics of the market is increasing the potential for the market players. The analysis of the market observes that the market is poised for an accelerated growth rate in the forthcoming years. Improved approachability to various resources and capabilities is projected to compel the growth of the market in the imminent forecast period. The use of successful strategy execution techniques is estimated to have a positive effect on the future growth of the market.
The prominent contenders in the CBD hemp oil market are Cannoid, ENDOCA, PharmaHemp,Elixinol, Folium Biosciences, Isodiol, Gaia Botanicals, Canopy Growth Corporation, Aurora Cannabis, Medical Marijuana, NuLeaf Naturals, CBD American Shaman, Aphria Inc., and others
Industry Updates:
Dec 2018 The US Congress has recently passed a bill that allows CBD products to be recognized as legal on the legislative level. The bill will allow the CBD products to be sold as products for consumers on retail store shelves. The bill also permits farmers to grow industrial hemp legally.
Related Reports

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at 4 comments:
Labels: , , , ,

Wednesday, 6 November 2019

Autism Disorder & Treatment Market - Global Industry Demand and Forecast to 2023



Autism Disorder & Treatment Market Information: By Type (Asperger Syndrome, Pervasive Developmental Disorder, Others), by Treatment Type (Aba, Hyperbaric Oxygen Therapy, and Others), by Drug (SSRIs, Anti-Convulsant, Others) – Global Forecast Till 2023


Global Autism Disorder and Treatment Market - Overview
Autism disorder affects a significant percentage of population. It can be characterized by a collection of multidimensional neurodevelopment disabilities characterized by social, behavioral and communication challenges. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, published in its recent report on ‘Global Autism Disorder and Treatment Market Research Report- Forecast To 2022’ that the market is anticipated to grow with a stellar CAGR percentage during the forecast period.
Despite manifold developments in the fields of medical sciences and technology, the cure for autism is still under development. Due to the substantial rate of cases that are detected the population group that the cure could be directed towards is vast. However the demand levels can be characterized as high for autism related therapy procedures and medications. The immense level of demand for this particular segment has spurred action from government bodies by way of initiatives to develop treatment methods for the autism spectrum.
Private bodies have also invested heavily in the treatment methods for discovering possible cures for autism through establishing various grants. Increased level of research and awareness drives by patients and prominent public figures has created more traction for this market. The market may find itself restricted due to lack of proper 
diagnostics to detect the disease, slow pace of R & D as compared to the number of cases being discovered.

Latest Industry Updates:
Dec 2017 Australia’s Zelda Therapeutics Ltd has teamed up with Children’s Hospital of Philadelphia (CHOP) to study the pharmacology of cannabinoids, with a focus on the potential for treating autism.
Nov 2017 Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, called NitroSynapsin, largely corrected electrical, behavioral and brain abnormalities in the mice. NitroSynapsin is intended to restore an electrical signaling imbalance in the brain found in virtually all forms of autism spectrum disorder (ASD).
Nov 2017 Researchers at the School of Medicine and at UCLA have received a $9.3 million grant from the National Institutes of Mental Health to study the ways that many genes associated with autism spectrum disorder may converge to affect a smaller number of molecular pathways or cellular processes responsible for the condition.
Mar 2017 In a new study, Juergen Hahn and Daniel Howsmon of Rensselaer Polytechnic Institute, New York, and colleagues present a method to identify a child as being on the autism spectrum based on concentrations of specific substances found in a blood sample.  The team is also hoping to study whether treatments could be used to alter the concentrations of FOCM and TS products and, if so, whether this could impact symptoms of autism spectrum disorder.
June 2017 In a small randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine have stated that a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.
March 2017 Servier, France’s largest independent pharma company, has entered into a partnership to accelerate the development of a medicine that could become the first treatment for the core symptoms of autism. It has signed an exclusive agreement with Marseille-based Neurochlore to develop and market bumetanide in pediatric autism in Europe. The development plan includes three Phase III trials with an oral liquid form designed for children.

Global Autism Disorder and Treatment Market - Competitive Analysis
With the entry of new industry players in the global autism disorder and treatment segment, a trend of solid, volume-driven growth has been observed in the market with the addition of new and advanced products. Companies are aiming to capture & solidify their share of the market segment, by competing and experimenting with various advantage points. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the optimal strategies.
Some of the key players in this market are GlaxoSmithKline plc (UK), Pfizer Inc. (US), Eli Lilly and Company (US). A few of the other players in the market are Allergan (Ireland), Merck & CO Inc. (US), Consern Pharma Private Limited (India).

Browse Complete Report Of Autism Disorder and Treatment Market Research Report - Forecast to 2023 @ https://www.marketresearchfuture.com/reports/autism-disorder-and-treatment-market-1605 

Global Autism Disorder and Treatment Market – Segments
Global Autism disorder and Treatment market has been segmented on the basis of types, treatment types, drugs and regions:
On The Basis Of Types: Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder & Others.
On The Basis Of Type of Treatment: Neurofeedback, Auditory Integration Training, Chelation Therapy, Hyperbaric Oxygen Therapy, Facilitated Communication and Others.
On The Basis of Drugs: SSRIS, Anti-Convulsants, Stimulants – Ritalin, Anti-Psychotic, Risperidone and Others.
On The Basis Of Region: North America, Europe, Asia Pacific and ROW.

Global Autism Disorder and Treatment Market - Regional Analysis
The global autism disorder and treatment market is segmented into four main geographic regions namely Americas, Europe, Asia-Pacific and Middle East and Africa. Globally North America is the largest market for Autism disorder and Treatment. The North American market for Autism disorder and Treatment is expected to grow at an exceptional CAGR% and is expected to reach Million dollar growth by the end of the forecasted period. This is primarily due to growing technology in the healthcare industry which is resulting in providing new effective drugs for treatments of patients. Europe is the second-largest market for Autism disorder and Treatment which is expected to grow at an affirmative CAGR%. Whereas Asia pacific is expected to be a growing market for Autism disorder and Treatment market and expected to grow at a rapid rate.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Tuesday, 5 November 2019

Renal Cancer Drug Market Trends and Business Outlook to 2019-2023

Global Renal Cancer Drug Market Research Report, by Therapeutic Class (Targeted Therapy and ImmunoTherapy), Pharmacologic Class (Angiogenesis Inhibitors), Type (Clear Cell, Papillary, Oncocytic), End-Users (Hospitals &clinics)–Global Forecast Till 2023
Market Highlights
The renal cancer drug market is expected to witness tremendous growth owing to the rising prevalence of high blood pressure. Other key factors such as the change to sedentary lifestyle, increase in smoking,
 growing consumption of alcohol are contributing to the growth of the market.  However, factors such as the high cost of surgical procedures, expensive chemotherapy treatments and the side effects and reaction associated with treatments are expected to restrict the market growth during the forecast period.
Segmentation
The global renal cancer market is segmented on the basis of therapeutic class, pharmacologic class, type, and end-user. The renal cancer drug market, by therapeutic class, is categorized into targeted therapy and immunotherapy. On the basis of pharmacologic class, the market is segmented into angiogenesis inhibitors, mTOR inhibitors, monoclonal antibodies and cytokine immunotherapy (IL-2). On the basis of type, the market is segmented into clear cell, papillary, chromophobe, oncocytic, collecting duct and other. On the basis of end- user the market is segmented hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers and other.
Regional Analysis
The Americas is the largest in the market owing to the increasing prevalence of stroke and high blood pressure and growing healthcare expenditure. The American Cancer Society estimated about14,970 people in 2018, will die due to kidney cancer in the US. Thus, the growing cases of kidney cancer facilitate the market growth in this region.
Europe (UK, Belgium, France, and Netherlands) is the second largest renal cancer drug market during the forecast period. The increasing occurrence of renal cancer drives the market in this region. According to Cancer Research UK in 2015, there were 12547 new cases of kidney cancer in the UK. Thus, the growing cases of kidney cancer facilitate the market growth.
Asia-Pacific was projected to be the fastest growing region for the global renal cancer drug market in 2017. The market is expected to witness growth owing to the rising prevalence of smoking and alcohol consumption in this region. According to the World Health Organization in 2015, 47.6% of people smoked tobacco in countries like China and Japan, respectively. This is expected to provide favorable backgrounds for the market to grow.
The Middle East and Africa accounts for the least share due to low per capita income and lack of availability of well-trained healthcare professionals. However, the rising oncology and new cancer treating technology both at the hospital level and in the community are expected to influence the market in a positive way.
Key Players
Some of the key players in the global renal cancer drug market are Novartis AG (Switzerland), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Genentech, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Cipla Limited (India), Active Biotech AB (Sweden), Amgen (US), Bayer AG (Germany), Bristol-Myers Squibb company (US).
Access Report @ https://www.marketresearchfuture.com/reports/renal-cancer-drug-market-6466
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Sunday, 3 November 2019

Healthcare Information Systems Market - Global Analysis, Industry Forecast, Business Development, Research Forecast by 2023

Healthcare Information Systems Market Highlights
The global healthcare information systems market is expected to grow at an approximate CAGR of 10.0% during forecast period, 2018–2023.
Health care information technology has shown to improve the quality of healthcare sector by enhancing disease surveillance, increased adherence to guidelines, and decreasing medication errors. The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times.

 Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/7325 

 Use of health care information systems in electronic prescriptions, medication management and intelligent wearable technologies to limit lifestyle diseases, and smart robots to systemize repetitive tasks is expected to significantly reduce health care costs and boost the market.

Healthcare Information Systems Market Segmentation
The global healthcare information systems market is segmented based on type, components, deployment, end user, and region.
On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management. The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others. The pharmacy information systems segment is sub-segmented into prescription management, automated dispensing systems, inventory management and others. The medical imaging information System is sub-segmented into radiology information systems, monitoring analysis software, picture archiving & communication systems and others. Based on components, the market is divided into two, i.e., Software and Hardware. Based on deployment, the market is divided into web-based, on premise and cloud-based. By end user, the market is divided into hospitals, diagnostics centre, academic and research institution, and others. On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.
Healthcare Information Systems Market Regional Analysis
The Americas leads the global healthcare information systems market. This can be attributed due to growing elderly population and presence of major market players within the region. Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth.
 In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure. Asia Pacific was estimated to be the fastest growing region in 2017. This can be attributed due to the high contamination rate, increasing household income and growing penetration of the market players within the region. Moreover, rapidly growing pharmaceutical sector within the region boosts the market to grow. On the other hand, the Middle East and Africa held the least share in the global healthcare information systems market. This can be attributed due to the presence of poor economies, stringent government policies and low per capita income, especially within the African region. A majority of the of the market share within the Middle East & Africa is estimated to be held by the Middle East due to increasing government funding for healthcare, improving healthcare facilities and presence of developed economies like United Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.
Key Players
Some of the key players in the global healthcare information systems market are Agfa-Gevaert N.V.
Allscripts Healthcare Solutions Inc., Athenahealth Inc., Carestream Health, Cerner Corporation
GE Healthcare, McKesson Corporation, Medidata Solutions Inc., NextGen Healthcare, Philips Healthcare, Siemens Healthineers.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/healthcare-information-systems-market-7325

Latest Research Reports 
Preclinical CRO Market Research Report - Global Forecast till 2024

CBD Oil Market Research Report - Global Forecast till 2024

Medical Marijuana Market Global Research Report - Forecast till 2023

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)